SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K, RVNC, CPTN On Behalf Of Shareholders
Date
10/17/2024 2:54:21 PM
(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Kellanova (NYSE: K)'s sale to Mars, Incorporated for $83.50 per share in cash. If you are a Kellanova shareholder, click here to learn more about your legal rights and options .
Revance Therapeutics, Inc. (NASDAQ: RVNC)'s sale to Crown Laboratories, Inc. for $6.66 per share in cash. If you are a Revance shareholder, click here to learn more about your rights and options .
Cepton, Inc. (NASDAQ: CPTN)'s sale to KOITO MANUFACTURING CO., LTD. for $3.17 per share in cash. If you are a Cepton shareholder, click here to learn more about your legal rights and options .
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email ... or ... .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
...
...
MENAFN17102024004107003653ID1108792841
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.